Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 2Plasma cell 1Lymphoid 1Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Ovarian Neoplasms 13Motor Activity 5Endometrial Neoplasms 5Breast Neoplasms 3Uterine Neoplasms 2Uterine Cervical Neoplasms 2Prostatic Neoplasms 2Neoplasms 2Fatigue 2Fallopian Tube Neoplasms 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Dysplasia 1Thyroid Neoplasms 1Smoking 1Rectal Neoplasms 1Multiple Myeloma 1Mesothelioma, Malignant 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Kidney Neoplasms 1Gynecologic Cancer 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Renal Cell 1Brenner Tumor 1Body Weight 1Appendiceal Neoplasms 1

Interventions

pembrolizumab 5Magnetic Resonance Spectroscopy 4Trastuzumab 3Nivolumab 3ulixertinib 2palbociclib 2lenvatinib 2belinostat 2Sunitinib 2Specimen Handling 2Fluorodeoxyglucose F18 2FAPI-46 2trastuzumab deruxtecan 1trastuzumab biosimilar HLX02 1trametinib 1tislelizumab 1tipifarnib 1spartalizumab 1sargramostim 1sapanisertib 1relatlimab 1pertuzumab 1pazopanib 1osimertinib 1omipalisib 1olaparib 1methyl N-acetylsibirosaminide 1larotrectinib 1ipatasertib 1erdafitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thyroid Neoplasms × Exercise × Gynecologic × Clear all
NCT04000880 2025-06-12

AMPLIFY

University of Alabama at Birmingham

Phase NA Active not recruiting
603 enrolled
BreastGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidPlasma cell

Breast Neoplasms, Kidney Neoplasms, Lymphoma, Non-Hodgkin, Motor Activity, Multiple Myeloma, Ovarian Neoplasms, Prostatic Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡